hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury
Status:
Completed
Trial end date:
2021-09-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is verify the efficacy and safety of Human Umbilical Cord
Mesenchymal Stem Cells (UC-MSC) therapy for patients with Healing Poor after Uterus Injury,
and exploring the possible mechanisms of umbilical cord mesenchymal stem cell therapy in
Healing Poor After Uterus Injury disease